SD, IL-13 Production Rate in IPF

NCT00532233 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: QAX576

Sponsor

Novartis Pharmaceuticals